Reliance Life Sci 
Welcome,         Profile    Billing    Logout  
 6 Products   2 Diseases  6 Products   7 Trials   245 News 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Infimab (infliximab biosimilar) / Sun Pharma, Reliance Life Sci
RTPR015a: A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of R-TPR-015 (1422015) in Patients With Active Rheumatoid Arthritis on stable dose of Methotrexate

Recruiting
3
189
India
R-TPR-015 (infliximab biosimilar)
Reliance Life Sciences
Rheumatoid arthritis
 
 
BOW015a: EPIRUS Biopharmaceuticals Announces Positive Phase 3 Data Supporting Biosimilarity of BOW-015 to Remicade®

Checkmark EULAR 2014
May 2014 - May 2014: EULAR 2014
Completed
3
189
RestOfWorld
BOW-015 (infliximab biosimilar)
Epirus
Rheumatoid arthritis
 
 
ReliPoietin (recombinant human erythropoietin biosimilar) / Reliance Life Sci
Relipoietin1: A clinical trial to evaluate efficacy and safety of Relipoietin in patients with anemia due to Kidney disease

Completed
3
75
India
ReliPoietin (recombinant human erythropoietin biosimilar)
Reliance Life Sciences
Anemia
 
 
RituxiRel (rituximab biosimilar) / Reliance Life Sci, Torrent Pharma
RLS/TP/2010/07, CTRI/2011/12/002232: To study the effects of two drugs, R-TPR-017 and Mabthera® (Ristova®) in cancer patients (Non-Hodgkin’s Lymphoma)

Recruiting
3
105
RestOfWorld
Rituximab code named R-TPR-017
Reliance Life Sciences Pvt Ltd , Reliance Life Sciences Pvt Ltd
Non-Hodgkins lymphoma
 
 
Neustim (molgramostim biosimilar) / Reliance Life Sci
NCT05886647: Non-invasive Neustimulation and Respiratory Rehabilitation

Recruiting
N/A
30
RoW
Active non-invasive stimulation and inspiratory muscle training, Sham compatorator and inspiratory muscle training
Suellen Andrade
Lung Diseases
06/24
11/24
ChiCTR2500100109: A Clinical Study on Targeted High-Precision Transcranial Alternating Current Stimulation Intervention in the Anterior Cingulate Cortex for Pancreatic Cancer Pain

Not yet recruiting
N/A
52
 
HD-tACS was delivered by a 4-channel noninvasive noninvasive neurostimulator (NeuStim, China), delivering alternating current (AC) through five circular Ag/AgC1 gel electrodes (3.14 cm).The 4x1 circular electrode configuration consisted of a center electrode (Fz) and four return electrodes (Fp1, Fp2, F7, and F8) that were embedded in a modular These electrodes were embedded in a modular EEG recording cap; the specific location of each electrode was determined by the International 10/20 EEG System, and the target brain region was the ACC. The stimulation protocol lasted approximately 20 min: the stimulation intensity was 4 mA, and the frequency was 13 Hz. For sham stimulation, all the electrodes were placed in the same location, and the same current intensity was delivered only during the first 10 seconds and the last 10 seconds of the 20-minute period to match the stimulation time of the real HD- tACS intervention. tACS intervention. Treatments were administered once daily for five consecutive days.; All electrodes were placed in the same position and the same current intensity was delivered only during the first 10 seconds and the last 10 seconds of the 20-minute period to match the stimulation time of the real HD-tACS intervention. Treatments were administered once daily for five consecutive days.
Naval Medical Center of PLA; Naval Medical Center of PLA, National Natural Science Foundation of China(8237053353)
Pancreatic Cancer Pain
 
 
RanizuRel (ranibizumab biosimilar) / Reliance Life Sci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Infimab (infliximab biosimilar) / Sun Pharma, Reliance Life Sci
RTPR015a: A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of R-TPR-015 (1422015) in Patients With Active Rheumatoid Arthritis on stable dose of Methotrexate

Recruiting
3
189
India
R-TPR-015 (infliximab biosimilar)
Reliance Life Sciences
Rheumatoid arthritis
 
 
BOW015a: EPIRUS Biopharmaceuticals Announces Positive Phase 3 Data Supporting Biosimilarity of BOW-015 to Remicade®

Checkmark EULAR 2014
May 2014 - May 2014: EULAR 2014
Completed
3
189
RestOfWorld
BOW-015 (infliximab biosimilar)
Epirus
Rheumatoid arthritis
 
 
ReliPoietin (recombinant human erythropoietin biosimilar) / Reliance Life Sci
Relipoietin1: A clinical trial to evaluate efficacy and safety of Relipoietin in patients with anemia due to Kidney disease

Completed
3
75
India
ReliPoietin (recombinant human erythropoietin biosimilar)
Reliance Life Sciences
Anemia
 
 
RituxiRel (rituximab biosimilar) / Reliance Life Sci, Torrent Pharma
RLS/TP/2010/07, CTRI/2011/12/002232: To study the effects of two drugs, R-TPR-017 and Mabthera® (Ristova®) in cancer patients (Non-Hodgkin’s Lymphoma)

Recruiting
3
105
RestOfWorld
Rituximab code named R-TPR-017
Reliance Life Sciences Pvt Ltd , Reliance Life Sciences Pvt Ltd
Non-Hodgkins lymphoma
 
 
Neustim (molgramostim biosimilar) / Reliance Life Sci
NCT05886647: Non-invasive Neustimulation and Respiratory Rehabilitation

Recruiting
N/A
30
RoW
Active non-invasive stimulation and inspiratory muscle training, Sham compatorator and inspiratory muscle training
Suellen Andrade
Lung Diseases
06/24
11/24
ChiCTR2500100109: A Clinical Study on Targeted High-Precision Transcranial Alternating Current Stimulation Intervention in the Anterior Cingulate Cortex for Pancreatic Cancer Pain

Not yet recruiting
N/A
52
 
HD-tACS was delivered by a 4-channel noninvasive noninvasive neurostimulator (NeuStim, China), delivering alternating current (AC) through five circular Ag/AgC1 gel electrodes (3.14 cm).The 4x1 circular electrode configuration consisted of a center electrode (Fz) and four return electrodes (Fp1, Fp2, F7, and F8) that were embedded in a modular These electrodes were embedded in a modular EEG recording cap; the specific location of each electrode was determined by the International 10/20 EEG System, and the target brain region was the ACC. The stimulation protocol lasted approximately 20 min: the stimulation intensity was 4 mA, and the frequency was 13 Hz. For sham stimulation, all the electrodes were placed in the same location, and the same current intensity was delivered only during the first 10 seconds and the last 10 seconds of the 20-minute period to match the stimulation time of the real HD- tACS intervention. tACS intervention. Treatments were administered once daily for five consecutive days.; All electrodes were placed in the same position and the same current intensity was delivered only during the first 10 seconds and the last 10 seconds of the 20-minute period to match the stimulation time of the real HD-tACS intervention. Treatments were administered once daily for five consecutive days.
Naval Medical Center of PLA; Naval Medical Center of PLA, National Natural Science Foundation of China(8237053353)
Pancreatic Cancer Pain
 
 
RanizuRel (ranibizumab biosimilar) / Reliance Life Sci
No trials found

Download Options